440354593
11 Dec 2018
Israel Celltrion and Teva Announce FDA Approval of TRUXIMA rituximab-abbs a Biosimilar to RITUXAN for Three Non-Hodgkins Lymphoma Indications, Israel
N/A
Banking, Finance, Insurance and Securities (BFIS) Tenders , Healthcare & Medical - Medical Tenders
Procurement News
Click for more details
If you have forgotten your User ID or Password, then please contact the TendersInfo Customercare by Email on customercare@tendersinfo.com.